H-ASQFVGSSIHWYQQR^-OH

Ref. 3D-PP48867

Produktinformation

• Name: H-ASQFVGSSIHWYQQR^-OH

Beschreibung

Peptide H-ASQFVGSSIHWYQQR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ASQFVGSSIHWYQQR^-OH include the following: Verification between original and biosimilar therapeutic antibody infliximab using nSMOL coupled LC-MS bioanalysis in human serum N Iwamoto, K Yokoyama, M Takanashi - Current , 2018 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpb/2018/00000019/00000006/art00007 Simultaneous quantification of free adalimumab and infliximab in human plasma using a target-based sample purification and liquid chromatography-tandem mass M El Amrani, SM Bosman, AC Egas - Therapeutic Drug , 2019 - journals.lww.comhttps://journals.lww.com/drug-monitoring/fulltext/2019/10000/Simultaneous_Quantification_of_Free_Adalimumab_and.14.aspx A generic approach for LC-MS/MS bioanalysis of therapeutic monoclonal antibodies in body fluids JH Toersche, AJ Kleinnijenhuis - Journal of Applied , 2015 - jab.scholasticahq.comhttps://jab.scholasticahq.com/article/436.pdf A generic sample preparation approach for LC-MS/MS bioanalysis of therapeutic monoclonal antibodies in serum applied to Infliximab AJ Kleinnijenhuis , JH Toersche - Journal of Applied , 2015 - researchgate.nethttps://www.researchgate.net/profile/Frederique-Van-Holthoon/publication/273312071_A_generic_sample_preparation_approach_for_LC-MSMS_bioanalysis_of_therapeutic_monoclonal_antibodies_in_serum_applied_to_Infliximab/links/5654340508aefe619b19bbc4/A-generic-sample-preparation-approach-for-LC-MS-MS-bioanalysis-of-therapeutic-monoclonal-antibodies-in-serum-applied-to-Infliximab.pdf Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data A Hentschel, G Piontek, R Dahlmann, P Findeisen - Clinical Proteomics, 2024 - Springerhttps://link.springer.com/article/10.1186/s12014-024-09464-x

• Marke: Biosynth